Neurodegenerative Disease

Investigating how soluble, oligomeric forms of Aβ can modulate novel cellular mechanisms that mediate neuronal and network-level excitability.

Researching the molecular mechanisms involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Studying mild cognitive impairment, which is a precursor to Alzheimer’s disease (AD), Down syndrome, and traumatic brain injury (TBI).

Translating findings in human patient samples into improved drug therapies for ALS patients.